• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.04% Nasdaq Down 1.11%

    Advaxis, Inc. (ADXS)

    -NasdaqCM
    22.75 Down 0.41(1.77%) May 26, 4:00PM EDT
    Add to Portfolio
    Prev Close:23.16
    Open:23.14
    Bid:21.25 x 1000
    Ask:22.88 x 400
    1y Target Est:23.17
    Beta:0.31
    Next Earnings Date:N/A
    Day's Range:21.78 - 23.31
    52wk Range:2.50 - 24.48
    Volume:981,064
    Avg Vol (3m):1,535,320
    Market Cap:680.00M
    P/E (ttm):N/A
    EPS (ttm):-0.97
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADXS

    Comparison

    Symbol% ChgMkt Cap
    ADXSDown 1.77%680.00M
    BVTI 0.00%N/A
    DNDN 0.00%N/A
    VICLDown 0.65%83.96M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):630.14
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Oct-15) :-1.12
    Quarterly EPS Est (Apr-15) :-0.28
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback